Form D · Other
OcuTerra Therapeutics, Inc.
Boston, MA · CIK 0001641226
Offering snapshot reported Feb 22, 2024 · SEC filing
- Reported sold
- $25.6M Offering amount: $25.6M
- Investors reported
- 279 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$6,658,827 → $25,625,440
- Reported investors84 → 279
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2024 | Amendment | $25,625,440 | $18,966,613vs Dec 22, 2023 | 279 | SEC filing |
| Dec 22, 2023 | Initial | $6,658,827 | No comparison | 84 | SEC filing |
| Aug 24, 2021 | Amendment | $31,525,965 | $16,916,557vs May 11, 2021 | 226 | SEC filing |
| May 11, 2021 | Initial | $14,609,408 | No comparison | 87 | SEC filing |
| Sep 26, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.56M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-500574
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group LLC | 120708 |
Source: Form D, filed Feb 22, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kerrie Brady | Director, Executive |
| Robert Dempsey | Director |
| David Scott Edwards | Executive, Promoter |
| D. Scott Edwards | Executive |
| Bruce Failing | Director |
| William H. Koster | Director |
| Joseph Pignato | Director |
| Robert Ruffolo | Director |
| Barbara Ryan | Director |
| Brenton Saunders | Director |
| Brent Saunders | Director |
| Robin Steele | Director |
| William Steinkrauss | Executive |
| David J. Tanzer | Executive |
| Michael Turner | Director |
Issuer details
Industry: Other (See others in industry)
Address:
85 E. India Row Suite 21 G
Boston, MA, 02110
Boston, MA, 02110